Maybe if the health insurance and pharmaceutical industries weren’t such grifters, people wouldn’t have to turn to ...
The Food and Drug Administration is reviewing a request for new warnings on antidepressant drugs, and that's presenting an unusual conflict of interest at the agency.
The FDA has issued 30 warning letters to telehealth companies over misleading claims about compounded GLP-1 drugs. Regulators ...
March 3 (Reuters) - The U.S. Food and Drug Administration has issued warning letters to 30 telehealth companies for making ...
March 3 (Reuters) - The U.S. Food and Drug Administration has warned Novo Nordisk over a consumer ad for its blockbuster ...
The U.S. Food and Drug Administration's (FDA) chief says the agency will begin offering bonuses to drug reviewers who ...
Over 100 chemicals of unknown safety were secretly added to foods and supplements without notifying the public or the FDA, a ...
A federal judge questioned Tuesday whether demand for abortion medication would go away even if he were to force the Trump ...
The head of the Food and Drug Administration plans to start offering bonus payments to agency drug reviewers who complete ...
2025 brought significant, fast-moving change to the U.S. Food and Drug Administration (FDA), and the organization has undergone extensive modifications as one component of President Donald Trump's ...
A recall of potentially harmful cat food has been expanded to include two additional lots of products, affecting 20 states, ...
The US Food and Drug Administration plans to give bonuses to scientific staff for speeding up drug reviews, according to an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results